A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
Clinical trial NCT02489318 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02489318
- Sponsor
- Aragon Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-27
- Primary completion
- 2020-09-07
- Enrollment
- 1052
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.